Literature DB >> 30530690

Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.

Hualong Wang1,2,3, Xia Liu1, Shengdi Chen4, Keqiang Ye5,6.   

Abstract

Alzheimer's disease (AD) neuropathological hallmarks include senile plaques with aggregated amyloid beta as a major component, neurofibrillary tangles (NFT) containing truncated and hyperphosphorylated Tau, extensive neuronal loss, and chronic neuroinflammation. However, the key molecular mechanism that dominates the pathogenesis of AD remains elusive for AD. Here we show that the C/EBPβ/δ-secretase axis is activated in an age-dependent manner in different brain regions of the 3×Tg AD mouse model, elevating δ-secretase-truncated APP and Tau proteolytic truncates and promoting senile plaques and NFT formation in the brain, associated with gradual neuronal loss and chronic neuroinflammation. Depletion of inflammatory cytokine-regulated transcription factor C/EBPβ from 3×Tg mice represses APP, Tau, and δ-secretase expression, which subsequently inhibits APP and Tau cleavage, leading to mitigation of AD pathologies. Knockout of δ-secretase from 3×Tg mice strongly blunts AD pathogenesis. Consequently, inactivation of the C/EBPβ/δ-secretase axis ameliorates cognitive dysfunctions in 3×Tg mice by blocking APP and Tau expression and their pathological fragmentation. Thus, our findings support the notion that C/EBPβ/δ-secretase axis plays a crucial role in AD pathogenesis.

Entities:  

Keywords:  AEP; Alzheimer’s disease; C/EBPβ; neurodegenerative diseases; δ-secretase

Mesh:

Substances:

Year:  2018        PMID: 30530690      PMCID: PMC6310855          DOI: 10.1073/pnas.1815915115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

2.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

Review 3.  The C/EBP family of transcription factors.

Authors:  A Wedel; H W Ziegler-Heitbrock
Journal:  Immunobiology       Date:  1995-07       Impact factor: 3.144

4.  Human secreted tau increases amyloid-beta production.

Authors:  Jessica Bright; Sami Hussain; Vu Dang; Sarah Wright; Bonnie Cooper; Tony Byun; Carla Ramos; Andrew Singh; Graham Parry; Nancy Stagliano; Irene Griswold-Prenner
Journal:  Neurobiol Aging       Date:  2014-09-16       Impact factor: 4.673

5.  Asparagine endopeptidase is required for normal kidney physiology and homeostasis.

Authors:  Gail Miller; Stephen P Matthews; Thomas Reinheckel; Stewart Fleming; Colin Watts
Journal:  FASEB J       Date:  2011-02-03       Impact factor: 5.191

6.  Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.

Authors:  Dongtao Ni Li; Stephen P Matthews; Antony N Antoniou; Daniela Mazzeo; Colin Watts
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

7.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Masashi Kitazawa; Bertrand P Tseng; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

8.  Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.

Authors:  Zhentao Zhang; Mingke Song; Xia Liu; Seong Su Kang; Duc M Duong; Nicholas T Seyfried; Xuebing Cao; Liming Cheng; Yi E Sun; Shan Ping Yu; Jianping Jia; Allan I Levey; Keqiang Ye
Journal:  Nat Commun       Date:  2015-11-09       Impact factor: 14.919

9.  CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures.

Authors:  Ron Strohmeyer; Jadd Shelton; Christopher Lougheed; Trisia Breitkopf
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.

Authors:  Zhi-Hao Wang; Ke Gong; Xia Liu; Zhentao Zhang; Xiaoou Sun; Zheng Zachory Wei; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Peter F Johnson; Jianping Jia; Jian-Zhi Wang; Keqiang Ye
Journal:  Nat Commun       Date:  2018-05-03       Impact factor: 14.919

View more
  12 in total

1.  FSH blockade improves cognition in mice with Alzheimer's disease.

Authors:  Jing Xiong; Seong Su Kang; Zhihao Wang; Xia Liu; Tan-Chun Kuo; Funda Korkmaz; Ashley Padilla; Sari Miyashita; Pokman Chan; Zhaohui Zhang; Pavel Katsel; Jocoll Burgess; Anisa Gumerova; Kseniia Ievleva; Damini Sant; Shan-Ping Yu; Valeriia Muradova; Tal Frolinger; Daria Lizneva; Jameel Iqbal; Ki A Goosens; Sakshi Gera; Clifford J Rosen; Vahram Haroutunian; Vitaly Ryu; Tony Yuen; Mone Zaidi; Keqiang Ye
Journal:  Nature       Date:  2022-03-02       Impact factor: 69.504

2.  C/EBPβ/AEP signaling couples atherosclerosis to the pathogenesis of Alzheimer's disease.

Authors:  Jianming Liao; Guiqin Chen; Xia Liu; Zheng Zachory Wei; Shan Ping Yu; Qianxue Chen; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 13.437

3.  Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer's disease mouse model.

Authors:  Chun Chen; Eun Hee Ahn; Seong Su Kang; Xia Liu; Ashfaqul Alam; Keqiang Ye
Journal:  Sci Adv       Date:  2020-07-29       Impact factor: 14.136

4.  A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.

Authors:  Yinan Yao; Seong Su Kang; Yiyuan Xia; Zhi-Hao Wang; Xia Liu; Thorsten Muller; Yi E Sun; Keqiang Ye
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

5.  ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer's disease.

Authors:  Zhi-Hao Wang; Yiyuan Xia; Pai Liu; Xia Liu; Laura Edgington-Mitchell; Kecheng Lei; Shan Ping Yu; Xiao-Chuan Wang; Keqiang Ye
Journal:  Prog Neurobiol       Date:  2021-03-11       Impact factor: 10.885

Review 6.  δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities.

Authors:  Zhentao Zhang; Ye Tian; Keqiang Ye
Journal:  Transl Neurodegener       Date:  2020-01-06       Impact factor: 8.014

Review 7.  Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.

Authors:  Piyush Padhi; Carter Worth; Gary Zenitsky; Huajun Jin; Kumar Sambamurti; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Front Neurosci       Date:  2022-02-25       Impact factor: 4.677

8.  Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.

Authors:  Chun Chen; Yunzhe Zhou; Hualong Wang; Ashfaqul Alam; Seong Su Kang; Eun Hee Ahn; Xia Liu; Jianping Jia; Keqiang Ye
Journal:  EMBO J       Date:  2021-07-14       Impact factor: 14.012

9.  Tau-induced upregulation of C/EBPβ-TRPC1-SOCE signaling aggravates tauopathies: A vicious cycle in Alzheimer neurodegeneration.

Authors:  Jinwang Ye; Ying Yin; Yaling Yin; Huaqiu Zhang; Huali Wan; Lu Wang; Yue Zuo; Di Gao; Mengzhu Li; Jun Li; Yanchao Liu; Dan Ke; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2020-08-20       Impact factor: 9.304

Review 10.  Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.

Authors:  Seong Su Kang; Eun Hee Ahn; Keqiang Ye
Journal:  Exp Mol Med       Date:  2020-08-28       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.